Mechanisms of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
基本信息
- 批准号:7455422
- 负责人:
- 金额:$ 38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-12-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAddressAnatomyArchitectureArtsAttenuatedBindingBiosensorBlood VesselsCell SurvivalCell VolumesCell membraneCellsChloride ChannelsChronicComplexConditionCytoskeletal ModelingCytoskeletonCytosolic Phospholipase A2DiseaseDisruptionElectrolytesExtracellular Signal Regulated KinasesFamilyFocal Adhesion Kinase 1FoundationsFunctional disorderGoalsGuanosine Triphosphate PhosphohydrolasesHTATIP geneHepaticHepatocyteHumanImageInjuryIntegrinsIon ChannelKineticsLaboratoriesLifeLiquid substanceLiverLiver diseasesMaintenanceMediatingMediator of activation proteinMetabolicMetabolismMolecularMovementNutrientOrganPLA2G4A genePathway interactionsPhospholipasePhospholipase A2PhosphotransferasesPhysiologicalPotassium ChlorideProcessProtein InhibitionReceptor SignalingRecoveryRegulationResearchRoleSamplingSignal TransductionSiteStressSwellingTestingTimeTravelTyrosine PhosphorylationVesicleWorkbasebile formationcell motilityextracellularhuman PLA2G4A proteinliver functionnovelphospholipase C gammapolymerizationpreventresponserestorationrhosensorsrc-Family Kinases
项目摘要
The ability to regulate volume is critical for the survival of cells. This is particularly true in the liver, which is
subjected to dynamic changes in osmotic load as a result of its role in nutrient processing, metabolism, and
bile formation. Disordered volume control leads to irreversible cell swelling that is a hallmark of acute and
chronic liver injury. Given the importance of this problem, the goals of this project are to understand how
hepatocellular volume, and by extension organ function, are maintained during osmotic stress. It is known
that such stress imposes dramatic changes in cell architecture, and that plasma membrane ion channels are
crucial to volume restoration after hepatocellular swelling. Recent work from this laboratory has suggested a
novel role for the tyrosine kinase Src in coordinating these actions. This proposal will test the hypothesis
that Src serves as a molecular switch that relays signals from volume-sensitive sensors to downstream
effectors that reorganize the cytoskeleton and activate fluid and electrolyte movement through potassium
and chloride channels. This maintains cell volume within a physiological state. The Specific Aims are: (1) to
establish the kinetics and cellular localization of volume-sensitive Src activation, (2) to determine the role of
Src in volume-sensitive cytoskeletal reorganization, and (3) to elucidate how Src regulates the activation of
volume-sensitive ion channels. Studies in Aim 1 will determine how Src influences the volume-sensitive
cellular localization and regulatory function of integrins, focal adhesion kinase (FAK), and the Src effectors
Vav and phospholipase C (PLC) gamma. It will also be tested whether the expression of Src or its effectors
is altered in human liver diseases manifested by hepatocyte ballooning. Studies in Aim 2 will test whether
inhibition of Src effectors modifies swelling-induced actin dynamics, and whether inhibition of these dynamics
attenuates volume recovery. Studies in Aim 3 will determine whether Src-dependent extracellular signal
receptor (ERK) kinases are regulated upon swelling by PLC gamma and/or Vav, and whether the ERK
effector phospholipase A2 regulates volume-sensitive potassium and chloride channels. The proposed
studies are expected to provide an integrated picture of mechanisms by which cell volume is regulated in the
liver. Since cell volume control is essential to the maintenance of organ level function, an understanding of
these mechanisms will provide new ways to prevent organ dysfunction in the setting of liver disease.
调节体积的能力对于细胞的生存至关重要。这在肝脏中尤其如此,肝脏
由于其在营养加工、代谢和代谢过程中的作用,渗透负荷会发生动态变化。
胆汁的形成。容量控制紊乱会导致不可逆的细胞肿胀,这是急性和慢性疾病的标志。
慢性肝损伤。鉴于这个问题的重要性,该项目的目标是了解如何
在渗透压过程中,肝细胞体积以及器官功能得以维持。我们都知道
这种压力会导致细胞结构发生巨大变化,并且质膜离子通道
对肝细胞肿胀后体积恢复至关重要。该实验室最近的工作表明
酪氨酸激酶 Src 在协调这些作用中发挥了新作用。该提案将检验假设
Src 充当分子开关,将信号从体积敏感传感器中继到下游
重组细胞骨架并通过钾激活液体和电解质运动的效应器
和氯离子通道。这将细胞体积维持在生理状态内。具体目标是: (1)
建立体积敏感 Src 激活的动力学和细胞定位,(2) 确定
Src 在体积敏感的细胞骨架重组中的作用,以及 (3) 阐明 Src 如何调节
体积敏感离子通道。目标 1 的研究将确定 Src 如何影响体积敏感
整合素、粘着斑激酶 (FAK) 和 Src 效应子的细胞定位和调节功能
Vav 和磷脂酶 C (PLC) γ。还将测试Src或其效应子的表达是否
在以肝细胞膨胀为表现的人类肝脏疾病中发生改变。目标 2 的研究将测试是否
抑制 Src 效应子会改变肿胀诱导的肌动蛋白动力学,以及抑制这些动力学是否会改变
削弱容量恢复。目标 3 的研究将确定 Src 依赖性细胞外信号是否
受体 (ERK) 激酶在肿胀时受 PLC γ 和/或 Vav 的调节,并且 ERK 是否
效应磷脂酶 A2 调节容量敏感的钾通道和氯通道。拟议的
预计研究将提供细胞体积调节机制的综合图景
肝。由于细胞体积控制对于维持器官水平功能至关重要,因此了解
这些机制将为预防肝病时器官功能障碍提供新的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN D LIDOFSKY其他文献
STEVEN D LIDOFSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN D LIDOFSKY', 18)}}的其他基金
METFORMIN FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
二甲双胍治疗非酒精性脂肪性肝炎
- 批准号:
7206938 - 财政年份:2005
- 资助金额:
$ 38万 - 项目类别:
Metformin for the Treatment of Non-Alcoholic Steatohepatitis
二甲双胍治疗非酒精性脂肪性肝炎
- 批准号:
7041551 - 财政年份:2004
- 资助金额:
$ 38万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Operating Grants